Gene Transfer Enhancement by Alkylcarboxylation of Poly(propylenimine)

Document Type: Research Paper

Authors

1 Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

2 School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

3 Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

10.7508/nmj.2013.01.007

Abstract

Abstract
Among synthetic carriers, dendrimers with the more flexible structure have attracted a great deal of researchers’ attention in the field of gene delivery. Followed by the promising results upon hydrophobic modification on polymeric structures in our laboratory, alkylcarboxylated poly (propylenimine)-based carriers were synthesized by nucleophilic substitution of amines with alkyl moieties and were further characterized for their physicochemical and biological characteristics for plasmid DNA delivery. Although not noticeably effective gene transfer activity for hexanoate- and hexadecanoate-modified series was observed, but alkylation by decanoic acid significantly improved the transfection efficiency of the final constructs up to 60 fold in comparison with unmodified poly(propylenimine) (PPI). PPI modified by 10-bromodecanoic acid at 50% grafting, showed significantly higher gene expression at c/p ratio of 2 compared to Superfect as positive control. 
Overall, modification of PPI with 50% primary amines grafting with 10-bromodecanoic acid could increase the transfection efficiency which is occurred at lower c/p ratio when compared to Superfect, i.e. less amount of modified vector is required to exhibit the same efficiency as Superfect. Therefore, the obtained constructs seem to be safer carriers for long-term gene therapy applications.

Keywords


  1. Li SD, Huang L. Non-viral is superior to viral gene delivery. Journal of controlled release; 2007; 123(3): 181-3.
    1. Dufes C, Uchegbu IF, Schatzlein AG. Dendrimers in gene delivery. Adv Drug Deliv Rev. 2005; 57(15): 2177-202.
    2. Parekh HS. The advance of dendrimers--a versatile targeting platform for gene/drug delivery. Current pharmaceutical design. 2007; 13(27): 2837-50.
    3. Nanjwade BK, Bechra HM, Derkar GK, Manvi FV, Nanjwade VK. Dendrimers: emerging polymers for drug-delivery systems. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2009 Oct 8; 38(3): 185-96.
    4. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, et al. A new class of polymers: starburst-dendritic macromolecules. Polym J. 1985; 17: 117-32.
    5. Shao N, Su Y, Hu J, Zhang J, Zhang H, Cheng Y. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity. International journal of nanomedicine. 2011; 6: 3361-72.
    6. Shishu, Maheshwari M. Dendrimers: The Novel Pharmaceutical Drug Carriers. International Journal of Pharmaceutical Sciences and Nanotechnology. 2009; 2(2): 493-502.
    7. Takahashi T, Hirose J, Kojima C, Harada A, Kono K. Synthesis of poly(amidoamine) dendron-bearing lipids with poly(ethylene glycol) grafts and their use for stabilization of nonviral gene vectors. Bioconjug Chem. 2007 Jul-Aug; 18(4): 1163-9.
    8. Wen Y, Guo Z, Du Z, Fang R, Wu H, Zeng X, et al. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives. Biomaterials. 2012 Nov; 33(32): 8111-21.
    9. Biswas S, Dodwadkar NS, Piroyan A, Torchilin VP. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials. 2012 Jun; 33(18): 4773-82.
    10. Russ V, Gunther M, Halama A, Ogris M, Wagner E. Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. J Control Release. 2008 Dec 8; 132(2): 131-40.
    11. Aldawsari H, Edrada-Ebel R, Blatchford DR, Tate RJ, Tetley L, Dufes C. Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex. Biomaterials. 2011 Sep; 32(25): 5889-99.
    12. Dehshahri A, Oskuee RK, Shier WT, Hatefi A, Ramezani M. Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine. Biomaterials. 2009 Sep; 30(25): 4187-94.
    13. Oskuee RK, Dehshahri A, Shier WT, Ramezani M. Alkylcarboxylate grafting to polyethylenimine: a simple approach to producing a DNA nanocarrier with low toxicity. The journal of gene medicine. 2009 Oct; 11(10): 921-32.
    14. Parhiz H, Hashemi M, Hatefi A, Shier WT, Farzad SA, Ramezani M. Molecular weight-dependent genetic information transfer with disulfide-linked polyethylenimine-based nonviral vectors. Journal of biomaterials applications. 2012 Aug 16; DOI: 10.1177/0885328212440344.
    15. Hashemi M, Parhiz BH, Hatefi A, Ramezani M. Modified polyethyleneimine with histidine-lysine short peptides as gene carrier. Cancer Gene Ther. 2011 ;18(1): 12-9.
    16. Forrest ML, Meister GE, Koerber JT, Pack DW. Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm Res. 2004 ;21(2): 365-71.
    17. Thomas M, Klibanov AM. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A. 2002; 99(23): 14640-5.
    18. Santos JL, Oliveira H, Pandita D, Rodrigues J, Pego AP, Granja PL, et al. Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J Control Release. 2010 May 21; 144(1): 55-64.
    19. Morales-Sanfrutos J, Megia-Fernandez A, Hernandez-Mateo F, Giron-Gonzalez MD, Salto-Gonzalez R, Santoyo-Gonzalez F. Alkyl sulfonyl derivatized PAMAM-G2 dendrimers as nonviral gene delivery vectors with improved transfection efficiencies. Org Biomol Chem. 2011 Feb 7; 9(3): 851-64.
    20. Eltoukhy AA, Chen D, Alabi CA, Langer R, Anderson DG. Degradable terpolymers with alkyl side chains demonstrate enhanced gene delivery potency and nanoparticle stability. Adv Mater. 2013 Mar 13; 25(10): 1487-93.
    21. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003; 55(3): 329-47.
    22. Geall AJ, Blagbrough IS. Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamine conjugate-DNA interactions for the analysis of lipoplex formation in gene therapy. J Pharm Biomed Anal. 2000 Jun; 22(5): 849-59.
    23. Gabrielson NP, Pack DW. Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules. 2006; 7(8): 2427-35.
    24. Doody AM, Korley JN, Dang KP, Zawaneh PN, Putnam D. Characterizing the structure/function parameter space of hydrocarbon-conjugated branched polyethylenimine for DNA delivery in vitro. J Control Release. 2006 Nov 28 ;116(2): 227-37.
    25. Tseng WC, Jong CM. Improved stability of polycationic vector by dextran-grafted branched polyethylenimine. Biomacromolecules. 2003 ;4(5):1277-84.
    26. Oskuee RK, Dehshahri A, Shier WT, Ramezani M. Alkylcarboxylate grafting to polyethylenimine: a simple approach to producing a DNA nanocarrier with low toxicity. J Gene Med. 2009 ;11(10):921-32.